TNF and Scheie syndrome: TLR-4-mediated TNF-α release is central to the inflammatory immune response observed in MPS I [104], with major impacts on synovial inflammation and joint disease [193,194], neuroinflammation [132,133], cardiovascular disease [195], and chronic pain [196].